Researchers identify potential target in myeloid malignancies
Researchers at Children's Hospital of Philadelphia (CHOP) have identified a molecule that plays a role in post-translational modification and activation in myeloid malignancies, making it a potential therapeutic target. The findings were published today in the Journal of Clinical Investigation.